Alpha Fusion
Osaka
About Alpha Fusion
Alpha Fusion produces astatine based radiopharmaceuticals for targeted alpha therapy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $6.9M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2024)
- Website: alpha-fusion.com
- Phone: [email protected]
Industries & Categories
Medical, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/alpha-fusion-7226 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.